78 related articles for article (PubMed ID: 24436316)
21. Aspirin and other nonsteroidal anti-inflammatory agents in the prevention of colorectal cancer.
Sandler RS
Important Adv Oncol; 1996; ():123-37. PubMed ID: 8791132
[TBL] [Abstract][Full Text] [Related]
22. Aspirin use and breast cancer risk: a meta-analysis and meta-regression of observational studies from 2001 to 2005.
Mangiapane S; Blettner M; Schlattmann P
Pharmacoepidemiol Drug Saf; 2008 Feb; 17(2):115-24. PubMed ID: 17955496
[TBL] [Abstract][Full Text] [Related]
23. Use of analgesic drugs and risk of ovarian cancer: results from a Danish case-control study.
Ammundsen HB; Faber MT; Jensen A; Høgdall E; Blaakaer J; Høgdall C; Kjaer SK
Acta Obstet Gynecol Scand; 2012 Sep; 91(9):1094-102. PubMed ID: 22646488
[TBL] [Abstract][Full Text] [Related]
24. Risk of esophageal and gastric adenocarcinomas in relation to use of calcium channel blockers, asthma drugs, and other medications that promote gastroesophageal reflux.
Vaughan TL; Farrow DC; Hansten PD; Chow WH; Gammon MD; Risch HA; Stanford JL; Schoenberg JB; Mayne ST; Rotterdam H; Dubrow R; Ahsan H; West AB; Blot WJ; Fraumeni JF
Cancer Epidemiol Biomarkers Prev; 1998 Sep; 7(9):749-56. PubMed ID: 9752982
[TBL] [Abstract][Full Text] [Related]
25. NO-releasing aspirin exerts stronger growth inhibitory effect on Barrett's adenocarcinoma cells than traditional aspirin.
Konturek PC; Kania J; Burnat G; Hahn EG
J Physiol Pharmacol; 2006 Dec; 57 Suppl 12():15-24. PubMed ID: 17244951
[TBL] [Abstract][Full Text] [Related]
26. Regular analgesic use and risk of endometrial cancer.
Moysich KB; Baker JA; Rodabaugh KJ; Villella JA
Cancer Epidemiol Biomarkers Prev; 2005 Dec; 14(12):2923-8. PubMed ID: 16365011
[TBL] [Abstract][Full Text] [Related]
27. Aspirin and other nonsteroidal anti-inflammatory drugs and risk of colorectal adenomatous polyps among endoscoped individuals.
Martínez ME; McPherson RS; Levin B; Annegers JF
Cancer Epidemiol Biomarkers Prev; 1995; 4(7):703-7. PubMed ID: 8672985
[TBL] [Abstract][Full Text] [Related]
28. Aspirin and risk of renal cell cancer in Italy.
Tavani A; Scotti L; Bosetti C; Dal Maso L; Montella M; Ramazzotti V; Negri E; Franceschi S; La Vecchia C
Eur J Cancer Prev; 2010 Jul; 19(4):272-4. PubMed ID: 20351553
[TBL] [Abstract][Full Text] [Related]
29. Nonsteroidal anti-inflammatory drug use and the risk of melanoma: a meta-analysis.
Hu H; Xie Y; Yang G; Jian C; Deng Y
Eur J Cancer Prev; 2014 Jan; 23(1):62-8. PubMed ID: 23549150
[TBL] [Abstract][Full Text] [Related]
30. Gastroesophageal reflux does not alter effects of body mass index on risk of esophageal adenocarcinoma.
Lagergren J; Mattsson F; Nyrén O
Clin Gastroenterol Hepatol; 2014 Jan; 12(1):45-51. PubMed ID: 23920035
[TBL] [Abstract][Full Text] [Related]
31. Breast cancer and nonsteroidal anti-inflammatory drugs: prospective results from the Women's Health Initiative.
Harris RE; Chlebowski RT; Jackson RD; Frid DJ; Ascenseo JL; Anderson G; Loar A; Rodabough RJ; White E; McTiernan A;
Cancer Res; 2003 Sep; 63(18):6096-101. PubMed ID: 14522941
[TBL] [Abstract][Full Text] [Related]
32. H2-receptor antagonists may increase the risk of cardio-oesophageal adenocarcinoma: a case-control study.
Suleiman UL; Harrison M; Britton A; McPherson K; Bates T
Eur J Cancer Prev; 2000 Jun; 9(3):185-91. PubMed ID: 10954258
[TBL] [Abstract][Full Text] [Related]
33. Alcohol consumption and the risks of adenocarcinoma and squamous cell carcinoma of the esophagus.
Pandeya N; Williams G; Green AC; Webb PM; Whiteman DC;
Gastroenterology; 2009 Apr; 136(4):1215-24, e1-2. PubMed ID: 19250648
[TBL] [Abstract][Full Text] [Related]
34. Association of aspirin and nonsteroidal anti-inflammatory drug use with breast cancer.
Johnson TW; Anderson KE; Lazovich D; Folsom AR
Cancer Epidemiol Biomarkers Prev; 2002 Dec; 11(12):1586-91. PubMed ID: 12496048
[TBL] [Abstract][Full Text] [Related]
35. Potential limitations of electronic database studies of prescription non-aspirin non-steroidal anti-inflammatory drugs (NANSAIDs) and risk of myocardial infarction (MI).
Ilkhanoff L; Lewis JD; Hennessy S; Berlin JA; Kimmel SE
Pharmacoepidemiol Drug Saf; 2005 Aug; 14(8):513-22. PubMed ID: 15959879
[TBL] [Abstract][Full Text] [Related]
36. Low-dose aspirin and risk of gastric and oesophageal cancer: A population-based study in the United Kingdom using The Health Improvement Network.
García Rodríguez LA; Soriano-Gabarró M; Vora P; Cea Soriano L
Int J Cancer; 2020 Nov; 147(9):2394-2404. PubMed ID: 32329063
[TBL] [Abstract][Full Text] [Related]
37. Red and processed meat intake and risk of esophageal adenocarcinoma: a meta-analysis of observational studies.
Huang W; Han Y; Xu J; Zhu W; Li Z
Cancer Causes Control; 2013 Jan; 24(1):193-201. PubMed ID: 23179661
[TBL] [Abstract][Full Text] [Related]
38. [Combination therapy with acetylsalicylic acid and non-aspirin nonsteroidal anti-inflammatory drugs].
Reuther LØ; Andersen SE
Ugeskr Laeger; 2006 Mar; 168(13):1310-4. PubMed ID: 16579883
[TBL] [Abstract][Full Text] [Related]
39. Risk factors for the development of esophageal adenocarcinoma in Barrett's esophagus.
de Jonge PJ; Steyerberg EW; Kuipers EJ; Honkoop P; Wolters LM; Kerkhof M; van Dekken H; Siersema PD
Am J Gastroenterol; 2006 Jul; 101(7):1421-9. PubMed ID: 16863542
[TBL] [Abstract][Full Text] [Related]
40. Regular aspirin use and lung cancer risk.
Moysich KB; Menezes RJ; Ronsani A; Swede H; Reid ME; Cummings KM; Falkner KL; Loewen GM; Bepler G
BMC Cancer; 2002 Nov; 2():31. PubMed ID: 12453317
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
